Company Overview
Snapshot
Founded in November 2020, TuneMe operates with 1–10 employees. The company has secured funding across one round from one investor, with eHealth Ventures participating in its Seed round in August 2024.
Business overview
TuneMe develops virtual assistance software that leverages artificial intelligence and voice analysis to create personalized treatments. The company's core technology incorporates innovative vibroacoustic neuro-stimulation to rebalance the autonomic nervous system. TuneMe offers a multi-platform neurostimulation solution specifically designed for individuals experiencing PTSD and sleep difficulties, operating within the Digital Therapeutics sector of Health Tech & Life Sciences.
Log in to access full profile ›Company Intelligence Q&A
- When was TuneMe founded?
- TuneMe was founded in November 2020.
- What is TuneMe's primary focus?
- TuneMe focuses on developing an AI-based app for stress regulation, utilizing vibroacoustic neuro-stimulation to rebalance the autonomic nervous system for individuals with PTSD and sleep difficulties.
- What is TuneMe's product stage?
- TuneMe's product is currently in the Clinical Trial stage, focusing on developing a multi-platform neurostimulation solution for PTSD and sleep difficulties.